Clarity in Cell Line Development Commercial stable cell line development for biopharmaceutical production and gene therapy is a high value process which is inherently expensive and takes a significant amount of time. Solentim® has established itself over the past seven years as a significant leader and innovator of new products in the cell line development arena.

Our Cell Metric® product range of bright field imaging stations has a large global installed base of customers, and we are recognised as a leader for documenting proof of clonal origin for Master Cell Banks in filings to the regulators.

We have most recently introduced a second-generation single cell printing system called VIPS™, for customers that are looking for a simpler, more reliable alternative to FACS and limiting dilution

Pin It on Pinterest